CBT Add to watchlist $73.32 1.25 (-1.68%) Last updated: Apr 16, 2026 02:30
52-Week Range
$73.32
$58.33 $73.32 $83.71

Fundamentals Overview

Cabot Corporation is in the middle of its 52-week range with low valuation, trading relatively flat today.

Valuation low

P/E 12.5 P/B 2.45 P/S 1.06

Intrinsic value (DCF)

+101.6% upside vs price

Profitability

Net margin 8.6%

Risk (Beta)

0.83 — in line vol

Earnings & growth

EPS $5.88 Rev -5.6% Profit +69.8% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 59% confidence Risk: Moderate Volatility — Beta 0.83. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +101.6% upside vs price · Analyst grade: A-

Pressures (Sell):

Sentiment weakening (6 downgrades) · 3M vs Basic Materials sector: -5.5%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$3.83B
P/E (TTM)
12.47
EPS (TTM)
$5.88
Dividend Yield
2.45%
52-Week Range
$58.33 - $83.71
Volume vs Avg
N/A
Beta
0.83

About

Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites. It also provides specialty carbons used in inks, coatings, pl...
Sector: Basic Materials
Headquarters: US
Employees: 4,151
IPO Date: Nov 1980
Beta: 0.83 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: A-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 5, Hold: 1, Neutral: 14, Outperform: 7, Underweight: 3.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $147.79; current price is $73.32. That’s a +101.6% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 12.47
DCF value (model) $147.79 (101.6% upside)
PEG (TTM) N/A
P/B (TTM) 2.45
P/S (TTM) 1.06
P/FCF (TTM) 9.55
Liquidity & enterprise
Current Ratio (TTM) 1.67
Quick Ratio (TTM) 1.09
Cash Ratio (TTM) 0.26
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 8.62%
Gross margin (TTM) 25.4%
Operating margin (TTM) 16.5%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CBT.

Analyst Sentiment at a Glance

A- Sentiment Weakening
Buy 5Hold 1Neutral 14Outperform 7Underweight 3
0 upgrades, 6 downgrades
Price Target Consensus
Current $73.32
Median $75.00
Consensus $78.00
Low consensus $74.00
High consensus $85.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
UBS maintain Neutral Neutral 2026-02-05
Mizuho downgrade Outperform Neutral 2026-02-05
UBS maintain Neutral Neutral 2026-01-12
Mizuho maintain Outperform Outperform 2025-12-18
JP Morgan maintain Underweight Underweight 2025-11-28
Mizuho maintain Outperform Outperform 2025-11-17
UBS maintain Neutral Neutral 2025-11-05
Mizuho maintain Outperform Outperform 2025-10-03
UBS maintain Neutral Neutral 2025-08-05
UBS maintain Neutral Neutral 2025-04-07
JP Morgan maintain Underweight Underweight 2025-02-21
Mizuho maintain Outperform Outperform 2025-01-07
JP Morgan downgrade Neutral Underweight 2024-11-11
Mizuho maintain Outperform Outperform 2024-11-05
JP Morgan maintain Neutral Neutral 2024-08-07
UBS maintain Neutral Neutral 2024-08-06
Mizuho maintain Buy Buy 2024-05-07
UBS maintain Neutral Neutral 2024-05-07
Deutsche Bank downgrade Buy Hold 2024-04-18
UBS downgrade Buy Neutral 2024-01-08
UBS maintain Buy Buy 2023-12-14
UBS maintain Buy Buy 2023-11-07
JP Morgan maintain Neutral Neutral 2023-08-11
JP Morgan maintain Neutral Neutral 2023-08-10
Credit Suisse maintain Outperform Outperform 2023-08-08
Credit Suisse maintain Outperform Outperform 2023-08-07
Loop Capital maintain Buy Buy 2023-06-20
Loop Capital maintain Buy Buy 2023-06-19
JP Morgan downgrade Overweight Neutral 2023-06-06
JP Morgan downgrade Overweight Neutral 2023-06-05